FDA advisory committee votes against testosterone replacement therapy Tlando Jan. 12, 2018 No Comments
Novel TrpC5 ion channel inhibitor shows promise in models of progressive kidney disease Jan. 9, 2018 No Comments
FDA approves expanded indication for Procysbito to include children 1 year of age and older Dec. 29, 2017 No Comments
Bayer initiates phase III studies in Japan of molidustat in nondialysis patients with renal anemia Dec. 28, 2017 No Comments
Dimerix and Proteomics partner to evaluate companion diagnostic for DMX-200 Dec. 15, 2017 No Comments